Compare RLAY & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | CBT |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.4B |
| IPO Year | 2020 | 1994 |
| Metric | RLAY | CBT |
|---|---|---|
| Price | $18.33 | $74.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 6 |
| Target Price | $27.58 | ★ $90.33 |
| AVG Volume (30 Days) | ★ 2.5M | 341.8K |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 2.56% |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ 2.77 |
| Revenue | $15,355,000.00 | ★ $3,713,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $60.51 | $3.16 |
| P/E Ratio | ★ N/A | $26.57 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $5.95 | $58.33 |
| 52 Week High | $21.27 | $94.53 |
| Indicator | RLAY | CBT |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 36.89 |
| Support Level | $17.67 | $72.92 |
| Resistance Level | $20.09 | $76.81 |
| Average True Range (ATR) | 0.97 | 1.52 |
| MACD | 0.10 | 0.04 |
| Stochastic Oscillator | 65.28 | 28.50 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.